Number of Shares
50,590.00
Current Holdings Value*
$10.60 Mil
% of Portfolio
0.62%
Total Estimate Gain
$980,212.76
% of Total Estimate Gain
8.43%

The U.S. Equity Portfolio's AbbVie Inc Holding Summary

As of 2025-03-31, The U.S. Equity Portfolio held 50,590.00 shares of AbbVie Inc(ABBV), totaling $10.60 Mil. This investment constitutes 0.62% of their stock portfolio, and The U.S. Equity Portfolio now holds 0% of the outstanding AbbVie Inc(ABBV) stock.

The initial trade took place in 2020Q2. And since then The U.S. Equity Portfolio has made 5 purchases of ABBV, at an average price of $161.54, for a total of 71,943.00 shares. In addition, there have been 4 sales at an average price of $138.98 for 21,353.00 shares. Based on historical transaction data and ABBV's current price of $190.44, The U.S. Equity Portfolio's estimated gain on his ABBV holdings is $980,212.76, reflecting a 8.43% gain to date.

The U.S. Equity Portfolio ABBV ($190.44) Holding Chart

The U.S. Equity Portfolio ABBV ($190.44) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1